Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-003708
Filing Date
2021-08-16
Accepted
2021-08-16 16:12:23
Documents
45
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR JUNE 30, 2021 coeptis_i10q-063021.htm   iXBRL 10-Q 539694
2 CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 coeptis_ex3101.htm EX-31.1 8306
3 CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 coeptis_ex3102.htm EX-31.2 8261
4 CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION coeptis_ex3201.htm EX-32.1 2423
5 CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION coeptis_ex3202.htm EX-32.2 2437
  Complete submission text file 0001683168-21-003708.txt   2514487

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ndyn-20210630.xsd EX-101.SCH 23034
7 XBRL CALCULATION FILE ndyn-20210630_cal.xml EX-101.CAL 44552
8 XBRL DEFINITION FILE ndyn-20210630_def.xml EX-101.DEF 63999
9 XBRL LABEL FILE ndyn-20210630_lab.xml EX-101.LAB 186425
10 XBRL PRESENTATION FILE ndyn-20210630_pre.xml EX-101.PRE 142364
11 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_i10q-063021_htm.xml XML 219595
Mailing Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Inc. (Filer) CIK: 0001819663 (see all company filings)

EIN.: 843998117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56194 | Film No.: 211178272
SIC: 2834 Pharmaceutical Preparations